FDA approves Johnson & Johnson nasal spray Spravato for depression

Health

Fda Approves Johnson & Johnson Nasal Spray Spravato For Depression

By CNBC

The Food and Drug Administration on Tuesday approved Johnson & Johnson 's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow. The spray, called Spravato, is now the first-ever ...Read more